Zoetis share price logo

Zoetis

NASDAQ: ZTS

Large Cap

$75.02

-1.66

(-2.16%)

as on

Zoetis Stock Performance

as on August 21, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $74.97
    $77.24
    downward going graph

    0.07%

    Downside

    2.96%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $71.45
    $160.48
    downward going graph

    4.76%

    Downside

    113.92%

    Upside

    downward going graph

Zoetis share price movements today

Previous Close
$76.68
Open
$76.50
Volume
2.4M
Market Cap
$30.5B
Dividend Yield
2.76%
Day's Low - High
$74.97 - $77.24
52 Week Low - High
$71.45 - $160.48

Zoetis Historical Returns

1 Month Return
-3.62 %
3 Month Return
-0.58 %
1 Year Return
-52.12 %
3 Year Return
-59.63 %
5 Year Return
-64.28 %

Zoetis Stock Fundamentals & Key Indicators

Check Zoetis market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$30.5B

EPS (TTM)

6.08

Dividend Yield

2.76%

Quarterly Earnings Growth YOY

0.01%

PE Ratio (TTM)

12.47

Industry PE ratio

16.453333333333333

PEG Ratio

2.7918180668016435

EBITDA

3.9B

Revenue (TTM)

9.5B

Profit Margin

70.87%

Return On Equity TTM

69.25%

Zoetis Stock Valuation

Track how Zoetis P/E has moved over time to understand its valuation trends.

Zoetis in the last 5 years

  • Overview

  • Trends

Lowest (20.87x)

December 31, 2025

Industry (16.45x)

December 31, 2025

Today (20.87x)

December 31, 2025

Highest (56.83x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 20.87x

Zoetis vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zoetis with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$30.5B-64.28%12.4770.87%2.76%
BUY$21.4B145.28%16.5886.14%NA
HOLD$18.6B9.88%-44.5634.83%2.9899999999999998%
BUY$42.7BNA19.814.55%126.42999999999999%
NA$39.0BNA59.9947.54%1.09%

Stock Returns calculator for Zoetis Stock including INR - Dollar returns

The Zoetis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Zoetis investment value today

Current value as on today

₹53,534

Returns

-₹46,466

(-46.47%)

Returns from Zoetis Stock

-₹51,320 (-51.32%)

Dollar Impact

₹4,854 (+4.85%)

Analyst Recommendation on Zoetis Stock

Based on 12 analysts

BUY

41.67%

Buy

58.33%

Hold

0.00%

Sell

Based on 12 analysts, 58.333333333333336% of analysts recommend a 'BUY' rating for Zoetis. Average target price of $100.94

Zoetis Share Price Target

Get share price movements and forecasts by analysts on Zoetis.

What analysts predicted

25.68%UPSIDE

Target Price

$100.94

Current Price

$75.02

Analyzed by

12 Analysts

Target

$100.94

Zoetis target price $100.94, a slight upside of 25.68% compared to current price of $75.02. According to 12 analysts rating.

Indian Investors' Interest in Zoetis Stock

Investment in Zoetis Shares on INDmoney has grown by 109.46% in the last 30 days, indicating increased investment activity.

Time period: to

Change:109.46% versus previous 30 day period

Search interest for Zoetis Stock has increased by 112% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:112% versus previous 30 day period

Zoetis Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
2,190
2,361
2,388
2,317
2,220
2,460
2,400
2,387
2,262
2,468
Gross Profit
1,510
1,658
1,652
1,576
1,566
1,778
1,685
1,644
1,621
1,795
Operating Income
801
906
920
765
846
989
936
826
822
937
EBITDA
935
970
1,056
911
988
1,083
1,069
939
939
927
Interest Expense
62
63
61
56
59
58
64
57
62
61
Depreciation
126
127
121
123
119
123
124
121
119
-
Income Before Tax
747
780
874
732
810
902
887
761
758
866
Income Tax Expense
148
156
182
151
179
184
166
158
157
175
Net Income
599
624
682
581
631
718
721
603
601
691
Net Profit Margin
68.95%
70.22%
69.18%
68.02%
70.54%
72.28%
70.21%
68.87%
71.66%
72.73%

Zoetis Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5,307
5,825
6,260
6,675
7,776
8,080
8,544
9,256
9,467
Gross Profit
3,443
3,797
4,113
4,458
5,312
5,476
5,834
6,396
6,673
Operating Income
1,727
1,881
2,018
2,269
2,803
2,928
3,069
3,392
3,597
EBITDA
1,942
2,210
2,455
2,686
3,172
3,358
3,685
3,872
4,069
Interest Expense
175
212
242
249
236
237
258
242
243
Depreciation
242
308
412
441
448
465
491
497
487
Income Before Tax
1,525
1,690
1,801
1,996
2,488
2,656
2,936
3,133
3,360
Income Tax Expense
663
266
301
360
454
545
596
637
687
Net Income
864
1,428
1,500
1,638
2,037
2,114
2,344
2,486
2,673
Net Profit Margin
64.88%
65.18%
65.70%
66.79%
68.31%
67.77%
68.28%
69.10%
70.49%

Zoetis Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
599
624
692
581
631
718
721
603
601
691
Operating Cash Flow
595
502
951
905
587
486
938
893
401
655
Investing Cash Flow
-131
-132
-178
126
-175
-247
-160
-166
-87
-300
Financing Cash Flow
-524
-763
-628
-745
-677
-564
-134
-495
-840
-813
Change in Cash
-66
-401
140
273
-266
-286
649
228
-509
-465

Zoetis Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
862
1,424
1,500
1,636
2,034
2,111
2,344
2,496
2,673
Operating Cash Flow
1,346
1,790
1,795
2,126
2,213
1,912
2,353
2,953
2,904
Investing Cash Flow
-270
-2,259
-504
-572
-458
-883
-777
-315
-748
Financing Cash Flow
-251
533
-951
123
-1,862
-904
-3,109
-2,660
-1,870
Change in Cash
837
38
332
1,670
-119
96
-1,540
-54
325

Mutual Funds that own Zoetis Stock

Check out the Mutual Funds with significant holdings in Zoetis.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
9.327112%
38541830
Fidelity Concord Street Trust
1.810438%
7481160
VANGUARD SPECIALIZED FUNDS
1.164561%
4812241
VANGUARD FENWAY FUNDS
1.131469%
4675498
VANGUARD INSTITUTIONAL INDEX FUNDS
0.620152%
2562618

Global Institutional Holdings in Zoetis

Funds
Holdings
Vanguard
11.25%
iShares
6.72%
SPDR
4.13%
Invesco
1.45%
Xtrackers
0.98%

Zoetis News & Key Events

  • img

    Today's Timeline - 10 August

    Mon, 08:14 PM

    -

    Zoetis shares underperform as competition rises; management cuts revenue and profit guidance amid declining veterinary visits.

    Tue, 01:31 AM

    -

    Michael Burry adds to his long position in Zoetis, citing potential for stabilization despite recent market challenges.

Insights on Zoetis

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 600.99M → 690.99M (in $), with an average increase of 13.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.26B → 2.46B (in $), with an average increase of 8.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation Common Stock has given 67.7% return, outperforming this stock by 119.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 125.4% return, outperforming this stock by 183.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, ZTS stock has moved down by -41.7%

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
OrganisationZoetis
Headquarters10 Sylvan Way, Parsippany, NJ, United States, 07054
IndustryDrug Manufacturers - Specialty & Generic
CEOMs. Kristin C. Peck
E-voting on sharesClick here to vote

Key Management of Zoetis

Name

Title

Ms. Jeannette Ferran Astorga

Executive VP of Corporate Affairs & Chief Sustainability Officer

Ms. Kristin C. Peck

CEO & Director

Mr. Wetteny N. Joseph C.P.A.

Executive VP & CFO

Ms. Roxanne Lagano

Executive VP, General Counsel & Corporate Secretary

Mr. Abhay U. Nayak

Executive VP & President of U.S. Commercial Operations

Ms. Julie A. Fuller

Executive VP, Chief Human Resources Officer & Global Operations

Dr. Robert J. Polzer Ph.D.

Scientific Advisor

Mr. Jamie Brannan

Executive VP & Chief Commercial Officer

Mr. Keith Sarbaugh

Executive VP & Chief Digital and Technology Officer

Mr. Steven Frank

Vice President of Investor Relations

FAQs

What is Zoetis share price today?

Zoetis share price today is $75.02 as on at the close of the market. Zoetis share today touched a day high of $77.24 and a low of $74.97.

What is the 52 week high and 52 week low for Zoetis share?

Zoetis share touched a 52 week high of $160.48 on and a 52 week low of $71.45 on . Zoetis stock price today i.e. is closed at $75.02,which is 53.25% down from its 52 week high and 5.00% up from its 52 week low.

What is Zoetis's market capitalisation today?

Zoetis market capitalisation is $0.03T as on .

How to invest in Zoetis Stock (ZTS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zoetis on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zoetis Shares that will get you 0.0200 shares as per Zoetis share price of $75.02 per share as on August 21, 2026 at 8:45 am IST.

What is the minimum amount required to buy Zoetis Stock (ZTS) from India?

Indian investors can start investing in Zoetis (ZTS) shares with as little as ₹95.695 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.95 in Zoetis stock (as per the Rupee-Dollar exchange rate as on ). Based on Zoetis share’s latest price of $75.02 as on August 21, 2026 at 8:45 am IST, you will get 0.1333 shares of Zoetis. Learn more about fractional shares .

What are the returns that Zoetis has given to Indian investors in the last 5 years?

Zoetis stock has given -64.28% share price returns and 28.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?